Abstract
Differentiation of B lymphocytes follows an ordered pathway marked by somatic rearrangements of immunoglobulin heavy- and light-chain genes in conjunction with cellular transitions1–4. Although low level constitutive transcription of the μ heavy-chain constant region (Cμ) genes may occur in early precursor cells5, activation of synthesis and translation of complete μ RNA is thought to accompany somatic rearrangements of DNA6. Cytoplasmic μ-chain protein serves as a marker for pre-B cells, the earliest cells committed to differentiation into B lymphocytes4,7,8. μ-chain gene expression in pre-B cells precedes rearrangement and expression of light-chain genes6,8. We now report that early human pre-B cells, Epstein–Barr virus transformed pre-B cells, and pre-B cell hybrid analogues, produce Cμ without the normally associated heavy-chain variable (VH) region. Approximately 5% of normal pre-B cells from adult human bone marrow produce these incomplete μ-chains. Pre-B cells from three patients with X-linked agammaglobulinaemia are exclusively of this immature form, producing Cμ without associated VH. This immune deficiency disease represents a block in differentiation secondary to failure to express VH genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brack, C., Hirama, M., Lenhard-Schuller, R. & Tonegawa, S. Cell 15, 1–14 (1978).
Early, P., Huang, H., Davis, M., Calame, K. & Hood, L. Cell 19, 981–992 (1980).
Perry, R., Kelley, D. & Coleclough, C. Proc. natn. Acad. Sci. U.S.A. 78, 247–251 (1981).
Cooper, M. D. J. clin. Immun. 1, 81–89 (1981).
Kemp, D., Harris, A. & Adams, J. Proc. natn. Acad. Sci. U.S.A. 77, 7400–7404 (1980).
Alt, F., Rosenberg, N., Lewis, S., Thomas, E. & Baltimore, D. Cell 27, 381–390 (1981).
Osmond, D. & Nossal, G. J. V. Cell Immun. 13, 132–138 (1974).
Leavitt, D. & Cooper, M. D. Cell 19, 617–624 (1981).
Schwaber, J., Lazarus, H. & Rosen, F. S. J. clin. Invest. 62, 302–310 (1978).
Schwaber, J., Lazarus, H. & Rosen, F. S. Proc. natn. Acad. Sci. U.S.A. 75, 2421–2423 (1978).
Schwaber, J. & Cohen, E. P. Nature 244, 444–446 (1973).
Lin, L. C. & Putnam, F. Proc. natn. Acad. Sci. U.S.A. 75, 2649–2653 (1978).
Pearl, E. et al. J. Immun. 120, 1169–1181 (1978).
Schwaber, J., Posner, M., Schlossman, S. & Lazarus, H. Hum. Immun. (in the press).
Littlefield, J. W. Expl Cell Res. 41, 190–196 (1966).
Davidson, R. Expl Cell Res. 55, 424–426 (1969).
Pelham, H. & Jackson, R. Eur. J. Biochem. 67, 247–256 (1976).
Thomas, P. Proc. natn. Acad. Sci. U.S.A. 77, 5201–5205 (1980).
Alt, F. et al. Cell 20, 293–301 (1980).
Gough, N. & Barnard, O. Proc. natn. Acad. Sci. U.S.A. 78, 509–513 (1981).
Treisman, R., Proudfoot, N. J., Shander, M. & Maniatis, T. Cell 29, 903–911 (1982).
Weigert, M., Gatmaitan, L., Loh, E., Schilling, J. & Hood, L. Nature 276, 785–790 (1978).
Favaloro, J., Treisman, R. & Kamen, R. Meth. Enzym. 68, 718–749 (1980).
Southern, E. J. molec. Biol. 98, 503–517 (1975).
Walker, I. & Harris, A. Nature 288, 290–293 (1980).
Walker, I. & Harris, A. J. Immun. 127, 561–566 (1981).
Croce, C. et al. Proc. natn. Acad. Sci. U.S.A. 76, 3416–3419 (1979).
Schwaber, J. & Rosen, F. S. J. clin. Immun. 2, 30–34 (1982).
Laemmli, U. Nature 227, 680–685 (1970).
Maizel, J. Methods in Virology Vol. 5 179–246 (Academic, New York, 1969).
Chirgwin, J., Przybyla, A., MacDonald, R. & Rutter, W. Biochemistry 18, 5294–5299 (1979).
Challberg, & Englund, P. Meth. Enzym. 65, 39–42 (1980).
Denhardt, D. T. Biochem. biophys. Res. Commun. 23, 641–647 (1966).
Orkin, S. H. Proc. natn. Acad. Sci. U.S.A. 75, 5950–5954 (1978).
Chaconas, G. & van de Sande, J. Meth. Enzym. 65, 75–85 (1980).
Maxam, A. & Gilbert, W. Meth. Enzym. 65, 499–559 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwaber, J., Molgaard, H., Orkin, S. et al. Early pre-B cells from normal and X-linked agammaglobulinaemia produce Cμ without an attached VH region. Nature 304, 355–358 (1983). https://doi.org/10.1038/304355a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/304355a0
This article is cited by
-
Expression of immunoglobulin genes in common variable immunodeficiency
Journal of Clinical Immunology (1991)
-
Evidence for male X chromosomal mosaicism in X-linked agammaglobulinemia
Human Genetics (1989)
-
Quantitation of μ mRNA byin situ hybridization reveals a correlation between B-maturation associated antigens and IgM gene activation in acute lymphatic leukemias
Medical Oncology and Tumor Pharmacotherapy (1988)
-
Abnormalities in DNA rearrangements of immunoglobulin gene loci in precursor B cells derived from X-linked agammaglobulinemia patient and a severe combined immunodeficiency patient
Immunogenetics (1988)
-
Mapping of a gene for X-linked agammaglobulinemia and evidence for genetic heterogeneity
Human Genetics (1986)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.